Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo
Horacio Almanza-Reyes, Sandra Moreno, Ismael Plascencia-López, Martha Alvarado-Vera, Leslie Patrón-Romero, Belén Borrego, Alberto Reyes-Escamilla, Daniel Valencia-Manzo, Alejandro Brun, Alexey Pestryakov, Nina Bogdanchikova
PLOS ONE, doi:10.1371/journal.pone.0256401
SARS-CoV-2 infection in hospital areas is of a particular concern, since the close interaction between health care personnel and patients diagnosed with COVID-19, which allows virus to be easily spread between them and subsequently to their families and communities. Preventing SARS-CoV-2 infection among healthcare personnel is essential to reduce the frequency of infections and outbreaks during the pandemic considering that they work in highrisk areas. In this research, silver nanoparticles (AgNPs) were tested in vitro and shown to have an inhibitory effect on SARS-CoV-2 infection in cultured cells. Subsequently, we assess the effects of mouthwash and nose rinse with ARGOVIT ® silver nanoparticles (AgNPs), in the prevention of SARS-CoV-2 contagion in health workers consider as highrisk group of acquiring the infection in the General Tijuana Hospital, Mexico, a hospital for the exclusive recruitment of patients diagnosed with COVID-19. We present a prospective randomized study of 231 participants that was carried out for 9 weeks (during the declaration of a pandemic). The "experimental" group was instructed to do mouthwash and nose rinse with the AgNPs solution; the "control" group was instructed to do mouthwashes and nose rinse in a conventional way. The incidence of SARS-CoV-2 infection was significantly lower in the "experimental" group (two participants of 114, 1.8%) compared to the "control" group (thirty-three participants of 117, 28.2%), with an 84.8% efficiency. We conclude that the mouth and nasal rinse with AgNPs helps in the prevention of SARS-CoV-2 infection in health personnel who are exposed to patients diagnosed with COVID-19.
References
Borrego, Lorenzo, Mota-Morales, Almanza-Reyes, Mateos et al., Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo, Nanomedicine Nanotechnology, Biol Med,
doi:10.1016/j.nano.2016.01.021
Butowt, Bilinska, SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection, ACS Chem Neurosci,
doi:10.1021/acschemneuro.9b00426
Casale, Rinaldi, Sabatino, Moffa, Ciccozzi, Could nasal irrigation and oral rinse reduce the risk for COVID-19 infection? International journal of immunopathology and pharmacology,
doi:10.1177/2058738420941757
Edgardo, Can a Nasal / Oral / Ocular Spray Inactivate and Prevent SARS-CoV-2 infection? A Can a Nasal / Oral / Ocular Spray Inactivate and Prevent SARS-CoV-2 infection? A hypothesis, Int J Odontostomat
Folegatti, Ewer, Aley, Angus, Becker et al., Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial, Lancet,
doi:10.1016/S0140-6736%2820%2931604-4
Gu, Gong, Zhang, Zheng, Gao et al., Multiple organ infection and the pathogenesis of SARS, J Exp Med,
doi:10.1084/jem.20050828
Guan, Zheng, He, Liu, Zhuang et al., Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China, Science,
doi:10.1126/science.1087139
Handwashing, Cdc, None
Ho, Zhang, Huang, Aung, Lim et al., Use of a real-time locating system for contact tracing of health care workers during the COVID-19 pandemic at an infectious disease center in singapore: Validation study, J Med Internet Res,
doi:10.2196/19437
Jackson, Anderson, Rouphael, Roberts, Makhene et al., An mRNA Vaccine against SARS-CoV-2-Preliminary Report, N Engl J Med,
doi:10.1056/NEJMoa2022483
Jaume, Yip, Cheung, Leung, Li et al., Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent Fc R Pathway, J Virol,
doi:10.1128/JVI.00671-11
Jeon, Ko, Lee, Choi, Byun et al., Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs, Antimicrob Agents Chemother,
doi:10.1128/AAC.00819-20
Jeremiah, Miyakawa, Morita, Yamaoka, Ryo, Potent antiviral effect of silver nanoparticles on SARS-CoV-2, Biochem Biophys Res Commun,
doi:10.1016/j.bbrc.2020.09.018
Keech, Albert, Cho, Robertson, Reed et al., Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine, N Engl J Med,
doi:10.1056/NEJMoa2026920
Khan, Parab, Paranjape, Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic, Am J Otolaryngol,
doi:10.1016/j.amjoto.2020.102618
Lan, Wei, Hsu, Christiani, Kales, Work-related COVID-19 transmission in six Asian countries/areas: A follow-up study, PLoS One,
doi:10.1371/journal.pone.0233588
Logunov, Dolzhikova, Shcheblyakov, Tukhvatulin, Zubkova et al., Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia, Lancet,
doi:10.1016/S0140-6736%2821%2900234-8
Making, Zhu, Zhang, Li, Yang, Personal protective equipment for COVID-19, N Engl J Med
Ochoa-Meza Ar, ´lvarez-Sa ´nchez, Cr, Barraza, Magallo ´n-Barajas, Silver nanoparticles enhance survival of white spot syndrome virus infected Penaeus vannamei shrimps by activation of its immunological system, Fish Shellfish Immunol,
doi:10.1016/j.fsi.2018.10.007
Park, Yu, Kim Y Il, Kim, Kim et al., Antiviral efficacies of FDA-approved drugs against SARS-COV-2 infection in ferrets, MBio,
doi:10.1128/mBio.01114-20
Peng, Xu, Li, Cheng, Zhou et al., Transmission routes of 2019-nCoV and controls in dental practice, Int J Oral Sci,
doi:10.1038/s41368-020-0075-9
Ren, Wang, Wu, Xiang, Guo et al., Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study, Chin Med J (Engl),
doi:10.1097/CM9.0000000000000722
Salleh, Naomi, Utami, Mohammad, Mahmoudi et al., The Potential of Silver Nanoparticles for Antiviral and Antibacterial Applications: A Mechanism of Action,
doi:10.3390/nano10081566
Schwartz, King, Protecting Healthcare Workers During the Coronavirus Disease 2019 (COVID-19) Outbreak: Lessons From Taiwan's Severe Acute Respiratory Syndrome Response, Clin Infect Dis,
doi:10.1093/cid/ciaa255
To, Tsang, Yip, Chan, Wu et al., Consistent Detection of 2019 Novel Coronavirus in Saliva, Clin Infect Dis,
doi:10.1093/cid/ciaa149
Uskoković, Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?, Nanomedicine (Lond),
doi:10.2217/nnm-2020-0163
Wee, Hsieh, Phua, Tan, Conceicao et al., Respiratory surveillance wards as a strategy to reduce nosocomial transmission of COVID-19 through early detection: The experience of a tertiary-care hospital in Singapore, Infect Control Hosp Epidemiol,
doi:10.1017/ice.2020.207
Wong, Kwong, Wu, Chan, Chu et al., Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong, J Hosp Infect,
doi:10.1016/j.jhin.2020.03.036
Yip, Cheung, Li, Bruzzone, Peiris et al., Investigation of Antibody-Dependent Enhancement (ADE) of SARS coronavirus infection and its role in pathogenesis of SARS, BMC Proc,
doi:10.1186/1753-6561-5-S8-P80
Zaki, Van Boheemen, Bestebroer, Osterhaus, Fouchier, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N Engl J Med,
doi:10.1056/NEJMoa1211721
Zhu, Guan, Li, Huang, Jiang et al., Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial, Lancet,
doi:10.1016/S0140-6736%2820%2931605-6
DOI record:
{
"DOI": "10.1371/journal.pone.0256401",
"ISSN": [
"1932-6203"
],
"URL": "http://dx.doi.org/10.1371/journal.pone.0256401",
"abstract": "<jats:p>SARS-CoV-2 infection in hospital areas is of a particular concern, since the close interaction between health care personnel and patients diagnosed with COVID-19, which allows virus to be easily spread between them and subsequently to their families and communities. Preventing SARS-CoV-2 infection among healthcare personnel is essential to reduce the frequency of infections and outbreaks during the pandemic considering that they work in high-risk areas. In this research, silver nanoparticles (AgNPs) were tested <jats:italic>in vitro</jats:italic> and shown to have an inhibitory effect on SARS-CoV-2 infection in cultured cells. Subsequently, we assess the effects of mouthwash and nose rinse with ARGOVIT<jats:sup>®</jats:sup> silver nanoparticles (AgNPs), in the prevention of SARS-CoV-2 contagion in health workers consider as high-risk group of acquiring the infection in the General Tijuana Hospital, Mexico, a hospital for the exclusive recruitment of patients diagnosed with COVID-19. We present a prospective randomized study of 231 participants that was carried out for 9 weeks (during the declaration of a pandemic). The \"experimental\" group was instructed to do mouthwash and nose rinse with the AgNPs solution; the \"control\" group was instructed to do mouthwashes and nose rinse in a conventional way. The incidence of SARS-CoV-2 infection was significantly lower in the \"experimental\" group (two participants of 114, 1.8%) compared to the \"control\" group (thirty-three participants of 117, 28.2%), with an 84.8% efficiency. We conclude that the mouth and nasal rinse with AgNPs helps in the prevention of SARS-CoV-2 infection in health personnel who are exposed to patients diagnosed with COVID-19.</jats:p>",
"author": [
{
"ORCID": "https://orcid.org/0000-0002-1874-3975",
"affiliation": [],
"authenticated-orcid": true,
"family": "Almanza-Reyes",
"given": "Horacio",
"sequence": "first"
},
{
"affiliation": [],
"family": "Moreno",
"given": "Sandra",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Plascencia-López",
"given": "Ismael",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Alvarado-Vera",
"given": "Martha",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Patrón-Romero",
"given": "Leslie",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Borrego",
"given": "Belén",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Reyes-Escamilla",
"given": "Alberto",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Valencia-Manzo",
"given": "Daniel",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0001-7865-538X",
"affiliation": [],
"authenticated-orcid": true,
"family": "Brun",
"given": "Alejandro",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0002-9034-4733",
"affiliation": [],
"authenticated-orcid": true,
"family": "Pestryakov",
"given": "Alexey",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Bogdanchikova",
"given": "Nina",
"sequence": "additional"
}
],
"container-title": "PLOS ONE",
"container-title-short": "PLoS ONE",
"content-domain": {
"crossmark-restriction": false,
"domain": [
"www.plosone.org"
]
},
"created": {
"date-parts": [
[
2021,
8,
19
]
],
"date-time": "2021-08-19T18:59:52Z",
"timestamp": 1629399592000
},
"deposited": {
"date-parts": [
[
2021,
8,
19
]
],
"date-time": "2021-08-19T19:00:23Z",
"timestamp": 1629399623000
},
"editor": [
{
"affiliation": [],
"family": "Hozbor",
"given": "Daniela Flavia",
"sequence": "first"
}
],
"funder": [
{
"DOI": "10.13039/100012934",
"award": [
"Development Program \"Priority 2030\""
],
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/100012934",
"id-type": "DOI"
}
],
"name": "Tomsk Polytechnic University"
}
],
"indexed": {
"date-parts": [
[
2025,
5,
5
]
],
"date-time": "2025-05-05T19:31:44Z",
"timestamp": 1746473504299,
"version": "3.37.3"
},
"is-referenced-by-count": 59,
"issue": "8",
"issued": {
"date-parts": [
[
2021,
8,
19
]
]
},
"journal-issue": {
"issue": "8",
"published-online": {
"date-parts": [
[
2021,
8,
19
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
8,
19
]
],
"date-time": "2021-08-19T00:00:00Z",
"timestamp": 1629331200000
}
}
],
"link": [
{
"URL": "https://dx.plos.org/10.1371/journal.pone.0256401",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "340",
"original-title": [],
"page": "e0256401",
"prefix": "10.1371",
"published": {
"date-parts": [
[
2021,
8,
19
]
]
},
"published-online": {
"date-parts": [
[
2021,
8,
19
]
]
},
"publisher": "Public Library of Science (PLoS)",
"reference": [
{
"key": "pone.0256401.ref001",
"unstructured": "World Health Organization. Archived: WHO Timeline—COVID-19. In: Archived: WHO Timeline—COVID-19 [Internet]. [cited 30 Jul 2020]. https://www.who.int/news-room/detail/27-04-2020-who-timeline--covid-19?gclid=CjwKCAjw34n5BRA9EiwA2u9k385WKHmODGM3irOwTWLJfwg96XUtxDPUzllPZWhrRxp5qAOCYmJMchoCEmwQAvD_BwE"
},
{
"key": "pone.0256401.ref002",
"unstructured": "World Health Organization. Coronavirus disease (COVID-19) pandemic. In: Coronavirus disease (COVID-19) pandemic. [Internet]. 2020. http://www.who.int/emergencies/diseases/novel-coronavirus-2019"
},
{
"key": "pone.0256401.ref003",
"unstructured": "Centers for Disease Control and Prevention. Symptoms of Coronavirus. 2020. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html"
},
{
"article-title": "Work-related COVID-19 transmission in six Asian countries/areas: A follow-up study",
"author": "FY Lan",
"first-page": "1",
"journal-title": "PLoS One",
"key": "pone.0256401.ref004",
"volume": "15",
"year": "2020"
},
{
"DOI": "10.1016/j.jhin.2020.03.036",
"article-title": "Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong",
"author": "SCY Wong",
"doi-asserted-by": "crossref",
"first-page": "119",
"journal-title": "J Hosp Infect",
"key": "pone.0256401.ref005",
"volume": "105",
"year": "2020"
},
{
"article-title": "Personal protective equipment for COVID-19",
"author": "MOF Making",
"first-page": "19",
"journal-title": "N Engl J Med",
"key": "pone.0256401.ref006",
"volume": "13",
"year": "2020"
},
{
"DOI": "10.1017/ice.2020.207",
"article-title": "Respiratory surveillance wards as a strategy to reduce nosocomial transmission of COVID-19 through early detection: The experience of a tertiary-care hospital in Singapore",
"author": "LE Wee",
"doi-asserted-by": "crossref",
"first-page": "820",
"journal-title": "Infect Control Hosp Epidemiol",
"key": "pone.0256401.ref007",
"volume": "41",
"year": "2020"
},
{
"article-title": "Use of a real-time locating system for contact tracing of health care workers during the COVID-19 pandemic at an infectious disease center in singapore: Validation study",
"author": "HJ Ho",
"journal-title": "J Med Internet Res",
"key": "pone.0256401.ref008",
"volume": "22",
"year": "2020"
},
{
"DOI": "10.1128/AAC.00819-20",
"article-title": "Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs",
"author": "S Jeon",
"doi-asserted-by": "crossref",
"journal-title": "Antimicrob Agents Chemother",
"key": "pone.0256401.ref009",
"volume": "64",
"year": "2020"
},
{
"article-title": "Antiviral efficacies of FDA-approved drugs against SARS-COV-2 infection in ferrets",
"author": "SJ Park",
"first-page": "1",
"journal-title": "MBio",
"key": "pone.0256401.ref010",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(21)00234-8",
"article-title": "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia",
"author": "DY Logunov",
"doi-asserted-by": "crossref",
"first-page": "671",
"journal-title": "Lancet (London, England)",
"key": "pone.0256401.ref011",
"volume": "397",
"year": "2021"
},
{
"DOI": "10.1016/S0140-6736(20)31605-6",
"article-title": "Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial",
"author": "FC Zhu",
"doi-asserted-by": "crossref",
"first-page": "479",
"journal-title": "Lancet",
"key": "pone.0256401.ref012",
"volume": "396",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)31604-4",
"article-title": "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",
"author": "PM Folegatti",
"doi-asserted-by": "crossref",
"first-page": "467",
"journal-title": "Lancet",
"key": "pone.0256401.ref013",
"volume": "396",
"year": "2020"
},
{
"DOI": "10.1056/NEJMoa2022483",
"article-title": "An mRNA Vaccine against SARS-CoV-2—Preliminary Report",
"author": "LA Jackson",
"doi-asserted-by": "crossref",
"first-page": "1920",
"journal-title": "N Engl J Med",
"key": "pone.0256401.ref014",
"volume": "383",
"year": "2020"
},
{
"DOI": "10.1056/NEJMoa2026920",
"article-title": "Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine",
"author": "C Keech",
"doi-asserted-by": "crossref",
"first-page": "2320",
"journal-title": "N Engl J Med",
"key": "pone.0256401.ref015",
"volume": "383",
"year": "2020"
},
{
"DOI": "10.1126/science.1087139",
"article-title": "Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China",
"author": "Y Guan",
"doi-asserted-by": "crossref",
"first-page": "276",
"journal-title": "Science (80-)",
"key": "pone.0256401.ref016",
"volume": "302",
"year": "2003"
},
{
"DOI": "10.1056/NEJMoa1211721",
"article-title": "Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia",
"author": "AM Zaki",
"doi-asserted-by": "crossref",
"first-page": "1814",
"journal-title": "N Engl J Med",
"key": "pone.0256401.ref017",
"volume": "367",
"year": "2012"
},
{
"DOI": "10.1097/CM9.0000000000000722",
"article-title": "Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study",
"author": "LL Ren",
"doi-asserted-by": "crossref",
"first-page": "1015",
"journal-title": "Chin Med J (Engl)",
"key": "pone.0256401.ref018",
"volume": "133",
"year": "2020"
},
{
"DOI": "10.1186/1753-6561-5-S1-P80",
"article-title": "Investigation of Antibody-Dependent Enhancement (ADE) of SARS coronavirus infection and its role in pathogenesis of SARS",
"author": "MS Yip",
"doi-asserted-by": "crossref",
"first-page": "P80",
"journal-title": "BMC Proc",
"key": "pone.0256401.ref019",
"volume": "5",
"year": "2011"
},
{
"DOI": "10.1128/JVI.00671-11",
"article-title": "Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent Fc R Pathway",
"author": "M Jaume",
"doi-asserted-by": "crossref",
"first-page": "10582",
"journal-title": "J Virol",
"key": "pone.0256401.ref020",
"volume": "85",
"year": "2011"
},
{
"DOI": "10.1016/S1386-6532(03)00195-1",
"article-title": "SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients",
"author": "L Li",
"doi-asserted-by": "crossref",
"first-page": "239",
"journal-title": "J Clin Virol",
"key": "pone.0256401.ref021",
"volume": "28",
"year": "2003"
},
{
"DOI": "10.1084/jem.20050828",
"article-title": "Multiple organ infection and the pathogenesis of SARS",
"author": "J Gu",
"doi-asserted-by": "crossref",
"first-page": "415",
"journal-title": "J Exp Med",
"key": "pone.0256401.ref022",
"volume": "202",
"year": "2005"
},
{
"DOI": "10.1016/j.fsi.2018.10.007",
"article-title": "Silver nanoparticles enhance survival of white spot syndrome virus infected Penaeus vannamei shrimps by activation of its immunological system",
"author": "AR Ochoa-meza",
"doi-asserted-by": "crossref",
"first-page": "1083",
"journal-title": "Fish Shellfish Immunol",
"key": "pone.0256401.ref023",
"volume": "84",
"year": "2019"
},
{
"DOI": "10.1016/j.nano.2016.01.021",
"article-title": "Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo",
"author": "B Borrego",
"doi-asserted-by": "crossref",
"journal-title": "Nanomedicine Nanotechnology, Biol Med",
"key": "pone.0256401.ref024",
"volume": "12",
"year": "2016"
},
{
"article-title": "The Potential of Silver Nanoparticles for Antiviral and Antibacterial Applications: A Mechanism of Action",
"author": "A Salleh",
"journal-title": "Nanomater (Basel, Switzerland)",
"key": "pone.0256401.ref025",
"volume": "10",
"year": "2020"
},
{
"DOI": "10.1016/j.bbrc.2020.09.018",
"article-title": "Potent antiviral effect of silver nanoparticles on SARS-CoV-2",
"author": "SS Jeremiah",
"doi-asserted-by": "crossref",
"first-page": "195",
"journal-title": "Biochem Biophys Res Commun",
"key": "pone.0256401.ref026",
"volume": "533",
"year": "2020"
},
{
"key": "pone.0256401.ref027",
"unstructured": "CDC. Handwashing | CDC. In: Handwashing [Internet]. [cited 12 Sep 2020]. https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/handwashing.html"
},
{
"DOI": "10.1093/cid/ciaa255",
"article-title": "Protecting Healthcare Workers During the Coronavirus Disease 2019 (COVID-19) Outbreak: Lessons From Taiwan’s Severe Acute Respiratory Syndrome Response",
"author": "J Schwartz",
"doi-asserted-by": "crossref",
"first-page": "858",
"journal-title": "Clin Infect Dis",
"key": "pone.0256401.ref028",
"volume": "71",
"year": "2020"
},
{
"article-title": "Could nasal irrigation and oral rinse reduce the risk for COVID-19 infection? International journal of immunopathology and pharmacology",
"author": "M Casale",
"first-page": "2058738420941757",
"journal-title": "England",
"key": "pone.0256401.ref029",
"year": "2020"
},
{
"author": "S Singh",
"journal-title": "Nasopharyngeal wash in preventing and treating upper respiratory tract infections : Could it prevent COVID-19?",
"key": "pone.0256401.ref030",
"year": "2020"
},
{
"article-title": "Can a Nasal / Oral / Ocular Spray Inactivate and Prevent SARS-CoV-2 infection? A Can a Nasal / Oral / Ocular Spray Inactivate and Prevent SARS-CoV-2 infection? A hypothesis",
"author": "F Edgardo",
"first-page": "2",
"journal-title": "Int J Odontostomat",
"key": "pone.0256401.ref031",
"year": "2020"
},
{
"DOI": "10.1093/cid/ciaa149",
"article-title": "Consistent Detection of 2019 Novel Coronavirus in Saliva",
"author": "KK-W To",
"doi-asserted-by": "crossref",
"first-page": "841",
"journal-title": "Clin Infect Dis",
"key": "pone.0256401.ref032",
"volume": "71",
"year": "2020"
},
{
"DOI": "10.1038/s41368-020-0075-9",
"article-title": "Transmission routes of 2019-nCoV and controls in dental practice",
"author": "X Peng",
"doi-asserted-by": "crossref",
"first-page": "9",
"journal-title": "Int J Oral Sci",
"key": "pone.0256401.ref033",
"volume": "12",
"year": "2020"
},
{
"DOI": "10.1016/j.amjoto.2020.102618",
"article-title": "Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic",
"author": "MM Khan",
"doi-asserted-by": "crossref",
"first-page": "102618",
"journal-title": "Am J Otolaryngol",
"key": "pone.0256401.ref034",
"volume": "41",
"year": "2020"
},
{
"article-title": "SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection",
"author": "R Butowt",
"first-page": "3",
"journal-title": "ACS Chem Neurosci",
"key": "pone.0256401.ref035",
"year": "2020"
},
{
"DOI": "10.2217/nnm-2020-0163",
"article-title": "Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?",
"author": "V Uskoković",
"doi-asserted-by": "crossref",
"first-page": "1719",
"journal-title": "Nanomedicine (Lond)",
"key": "pone.0256401.ref036",
"volume": "15",
"year": "2020"
}
],
"reference-count": 36,
"references-count": 36,
"relation": {
"has-preprint": [
{
"asserted-by": "object",
"id": "10.1101/2021.05.20.21256197",
"id-type": "doi"
}
]
},
"resource": {
"primary": {
"URL": "https://dx.plos.org/10.1371/journal.pone.0256401"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo",
"type": "journal-article",
"update-policy": "https://doi.org/10.1371/journal.pone.corrections_policy",
"volume": "16"
}